The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2018

Filed:

May. 14, 2015
Applicant:

The Trustees of Columbia University IN the City of New York, New York, NY (US);

Inventors:

Gerard M Turino, New York, NY (US);

Shuren Ma, Cliffside Park, NJ (US);

Yong Y Lin, Bridgewater, NJ (US);

Seymour Leiberman;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 27/62 (2006.01); G01N 33/68 (2006.01); H01J 49/00 (2006.01); G01N 30/72 (2006.01); G01N 30/88 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6887 (2013.01); G01N 27/62 (2013.01); G01N 30/7233 (2013.01); G01N 33/6848 (2013.01); G01N 33/6881 (2013.01); H01J 49/005 (2013.01); H01J 49/0027 (2013.01); G01N 2030/8831 (2013.01); G01N 2333/78 (2013.01); G01N 2500/00 (2013.01); G01N 2500/10 (2013.01); G01N 2800/00 (2013.01); G01N 2800/122 (2013.01); Y10T 436/145555 (2015.01);
Abstract

The present invention relates to methods of diagnosing, monitoring, and treating elastin fiber injuries. In additional preferred embodiments, the present invention relates to methods of validating candidate compounds for use in treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, refractory asthma, and other related diseases. Examples of such methods include determining if the candidate compound decreases the degradation of elastic fiber in a patient administered the candidate compound by measuring, using mass spectrometry employing an internal standard, a marker of elastic fiber degradation in a sample of a body fluid or a tissue of the patient. The invention provides that a decrease in the presence of the marker compared to a control validates that the candidate compound is effective to treat, prevent, or ameliorate the disease.


Find Patent Forward Citations

Loading…